These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
498 related items for PubMed ID: 24792533
1. Enantioselective and sensitive determination of carvedilol in human plasma using chiral stationary-phase column and reverse-phase liquid chromatography with tandem mass spectrometry. Jiang J, Tian L, Huang Y, Yan Y, Li Y. J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun 01; 960():92-7. PubMed ID: 24792533 [Abstract] [Full Text] [Related]
2. A validated enantioselective LC-MS/MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4'-hydroxyphenyl metabolite in human plasma: application to a clinical pharmacokinetic study. Furlong MT, He B, Mylott W, Zhao S, Mariannino T, Shen J, Stouffer B. J Pharm Biomed Anal; 2012 Nov 01; 70():574-9. PubMed ID: 22709607 [Abstract] [Full Text] [Related]
3. Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry. Poggi JC, Da Silva FG, Coelho EB, Marques MP, Bertucci C, Lanchote VL. Chirality; 2012 Mar 01; 24(3):209-14. PubMed ID: 22271587 [Abstract] [Full Text] [Related]
4. UPLC-MS/MS assay for the simultaneous quantification of carvedilol and its active metabolite 4'-hydroxyphenyl carvedilol in human plasma to support a bioequivalence study in healthy volunteers. Patel DP, Sharma P, Sanyal M, Singhal P, Shrivastav PS. Biomed Chromatogr; 2013 Aug 01; 27(8):974-86. PubMed ID: 23483571 [Abstract] [Full Text] [Related]
5. Enantioselective quantification of carvedilol in human plasma by HPLC in heavily medicated heart failure patients. Zakrzewski-Jakubiak M, de Denus S, Leblanc MH, White M, Turgeon J. J Pharm Biomed Anal; 2010 Aug 01; 52(4):636-41. PubMed ID: 20189739 [Abstract] [Full Text] [Related]
6. Simultaneous quantification of carvedilol and its metabolites in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and pharmacokinetic application. Li J, Wang L, Wang S, Chen M, Gu E, Hu G, Ge R. J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan 01; 974():138-46. PubMed ID: 25463209 [Abstract] [Full Text] [Related]
7. Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry. Jeong DW, Kim YH, Ji HY, Youn YS, Lee KC, Lee HS. J Pharm Biomed Anal; 2007 Jun 28; 44(2):547-52. PubMed ID: 17270380 [Abstract] [Full Text] [Related]
8. Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical pharmacokinetic study. Nardotto GHB, Coelho EB, Marques MP, Lanchote VL. J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar 15; 1015-1016():173-180. PubMed ID: 26927877 [Abstract] [Full Text] [Related]
9. Enantioselective determination of doxazosin in human plasma by liquid chromatography-tandem mass spectrometry using ovomucoid chiral stationary phase. Liu K, Zhong D, Chen X. J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep 15; 878(26):2415-20. PubMed ID: 20732837 [Abstract] [Full Text] [Related]
12. Enantioselective determination of 3-n-butylphthalide (NBP) in human plasma by liquid chromatography on a teicoplanin-based chiral column coupled with tandem mass spectrometry. Diao X, Ma Z, Lei P, Zhong D, Zhang Y, Chen X. J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov 15; 939():67-72. PubMed ID: 24103433 [Abstract] [Full Text] [Related]
13. Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. Wang S, Cyronak M, Yang E. J Pharm Biomed Anal; 2007 Jan 17; 43(2):701-7. PubMed ID: 16959461 [Abstract] [Full Text] [Related]
15. Simultaneous quantification of vortioxetine, carvedilol and its active metabolite 4-hydroxyphenyl carvedilol in rat plasma by UPLC-MS/MS: Application to their pharmacokinetic interaction study. Huang Y, Zheng S, Pan Y, Li T, Xu ZS, Shao MM. J Pharm Biomed Anal; 2016 Sep 05; 128():184-190. PubMed ID: 27262994 [Abstract] [Full Text] [Related]
16. Stereoselective analysis of carvedilol in human plasma using HPLC/MS/MS after chiral derivatization. Yang E, Wang S, Kratz J, Cyronak MJ. J Pharm Biomed Anal; 2004 Nov 15; 36(3):609-15. PubMed ID: 15522537 [Abstract] [Full Text] [Related]
17. Application of liquid chromatography-tandem mass spectrometry method for the analysis of new nonselective beta-adrenergic blocker 1-(1-H-indol-4-yloxy)-3-{[2-(2-methoxy phenoxy)ethylo]amino}propan-2-ol (2F109) in rat plasma. Walczak M, Szafarz M, Szymura-Oleksiak J, Groszek G, Bednarski M, Filipek B. Chirality; 2007 Jul 15; 19(7):536-41. PubMed ID: 17457833 [Abstract] [Full Text] [Related]
18. Quantification of carvedilol in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to bioequivalence study. do Carmo Borges NC, Mendes GD, de Oliveira Silva D, Marcondes Rezende V, Barrientos-Astigarraga RE, De Nucci G. J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug 05; 822(1-2):253-62. PubMed ID: 16005691 [Abstract] [Full Text] [Related]
19. Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization. Peccinini RG, Ximenes VF, Cesarino EJ, Lanchote VL. Biopharm Drug Dispos; 2008 Jul 05; 29(5):280-8. PubMed ID: 18551504 [Abstract] [Full Text] [Related]
20. Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study. Rathod R, Prasad LP, Rani S, Nivsarkar M, Padh H. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 01; 857(2):219-23. PubMed ID: 17702675 [Abstract] [Full Text] [Related] Page: [Next] [New Search]